TY - JOUR
T1 - Focal superior quadrant haemorrhages in post COVID-19 patient: A target for personalized medicine
AU - Savastano, Maria Cristina
AU - Culiersi, Carola
AU - Savastano, Alfonso
AU - Gambini, Gloria
AU - Caporossi, Tomaso
AU - Rizzo, Stanislao
PY - 2021
Y1 - 2021
N2 - Purpose: To report a case of multiple superior quadrant intraretinal haemorrhages in post-COVID-19 patient. Case description: A 58-year-old male with a history of coronary artery disease and hypertension, presented with multiple superior quadrant intraretinal haemorrhages in the superonasal quadrant of the left eye 1 month after hospitalization for COVID-19. The right eye was normal. During his 10-day stay, he was treated with hydroxychloroquine, lopinavir + ritonavir, ceftriaxone, and his pre-existing antiplatelet therapy. During hospitalization, a complete medical work up showed an anomalous increase in D-dimer. He did not require intensive care support. Conclusions: In this report, we focused on the origin of retinal bleeding in a post COVID-19 patient, likely due to a focal occlusion of a vessel. Considering the nature of SARS-CoV-2 infection, we hypothesize that retinal haemorrhages were caused by a combination of factors including the patient’s antiplatelet therapy and the thrombotic microvascular injury caused by the virus.
AB - Purpose: To report a case of multiple superior quadrant intraretinal haemorrhages in post-COVID-19 patient. Case description: A 58-year-old male with a history of coronary artery disease and hypertension, presented with multiple superior quadrant intraretinal haemorrhages in the superonasal quadrant of the left eye 1 month after hospitalization for COVID-19. The right eye was normal. During his 10-day stay, he was treated with hydroxychloroquine, lopinavir + ritonavir, ceftriaxone, and his pre-existing antiplatelet therapy. During hospitalization, a complete medical work up showed an anomalous increase in D-dimer. He did not require intensive care support. Conclusions: In this report, we focused on the origin of retinal bleeding in a post COVID-19 patient, likely due to a focal occlusion of a vessel. Considering the nature of SARS-CoV-2 infection, we hypothesize that retinal haemorrhages were caused by a combination of factors including the patient’s antiplatelet therapy and the thrombotic microvascular injury caused by the virus.
KW - Antiplatelet therapy
KW - COVID-19
KW - arterial occlusion
KW - coagulopathy
KW - sub-internal limiting membrane haemorrhage
KW - Antiplatelet therapy
KW - COVID-19
KW - arterial occlusion
KW - coagulopathy
KW - sub-internal limiting membrane haemorrhage
UR - http://hdl.handle.net/10807/201412
U2 - 10.1177/11206721211021296
DO - 10.1177/11206721211021296
M3 - Article
SN - 1120-6721
SP - 11206721211021296-N/A
JO - European Journal of Ophthalmology
JF - European Journal of Ophthalmology
ER -